Search

Your search keyword '"Hammermann J"' showing total 133 results
Start Over Author "Hammermann J"
133 results on '"Hammermann J"'

5. Detection of MLL/AF4 Recombination by PCR Technique

Author

Borkhardt, A., Repp, R., Hammermann, J., Brettreich, S., Gossen, R., Haupt, E., Harbott, J., Lampert, F., Hiddemann, W., editor, Plunkett, W., editor, Büchner, T., editor, Ritter, J., editor, Wörmann, B., editor, Keating, M. J., editor, and Creutzig, U., editor

Published
1996
Full Text
View/download PDF

6. Diagnose der Mukoviszidose (S2)

Author

NÄHRLICH, L., primary, STUHRMANN-SPANGENBERG, M., additional, BARBEN, J., additional, BARGON, J., additional, BLANKENSTEIN, O., additional, BREMER, W., additional, BRUNSMANN, F., additional, BUCHHOLZ, T., additional, ELLEMUNTER, H., additional, FUSCH, C., additional, GEMBRUCH, U., additional, HAMMERMANN, J., additional, JACOBEIT, J., additional, JUNG, A., additional, KEIM, V., additional, KOPP, I., additional, LOFF, S., additional, MAYR, S., additional, PFEIFFER-AULER, S., additional, ROSSI, R., additional, SITTER, H., additional, STERN, M., additional, STRASSBURG, C., additional, and DERICHS, N., additional

Published
2015
Full Text
View/download PDF

8. MOLECULAR ANALYSIS OF STAPHYLOCOCCUS AUREUS ISOLATES FROM AN ONGOING PROSPECTIVE OBSERVATIONAL LONGITUDINAL MULTICENTER STUDY DETERMINING STAPHYLOCOCCUS AUREUS AIRWAY COLONIZATION OR INFECTION IN CYSTIC FIBROSIS PATIENTS: 307

Author

Braun, N., Duebbers, A., Kuester, P., Ellemunter, H., Heuer, E., Sextro, W., Junge, S., Tuemmler, B., Mellies, U., Teschler, H., Mainz, J. G., Riethmueller, J., Graepler-Mainka, U., Koerner-Rettberg, C., Ballmann, M., Szczepanski, R., Wald, A., Wisbauer, M., Adelsberger, D., Staab, D., Wollschläger, B., Hammermann, J., Peters, G., Becker, K., and Kahl, B. C.

Published
2011

14. S3-Leitlinie: Lungenerkrankung bei Mukoviszidose – Modul 2: Diagnostik und Therapie bei der chronischen Infektion mit Pseudomonas aeruginosa

Author

Schwarz, C., additional, Schulte-Hubbert, B., additional, Bend, J., additional, Abele-Horn, M., additional, Baumann, I., additional, Bremer, W., additional, Brunsmann, F., additional, Dieninghoff, D., additional, Eickmeier, O., additional, Ellemunter, H., additional, Fischer, R., additional, Grosse-Onnebrink, J., additional, Hammermann, J., additional, Hebestreit, H., additional, Hogardt, M., additional, Hügel, C., additional, Hug, M., additional, Illing, S., additional, Jung, A., additional, Kahl, B., additional, Koitschev, A., additional, Mahlberg, R., additional, Mainz, J., additional, Mattner, F., additional, Mehl, A., additional, Möller, A., additional, Muche-Borowski, C., additional, Nüßlein, T., additional, Puderbach, M., additional, Renner, S., additional, Rietschel, E., additional, Ringshausen, F., additional, Schmidt, S., additional, Sedlacek, L., additional, Sitter, H., additional, Smaczny, C., additional, Tümmler, B., additional, Vonberg, R., additional, Wielpütz, M., additional, Wilkens, H., additional, Wollschläger, B., additional, Zerlik, J., additional, Düesberg, U., additional, and van Koningsbruggen-Rietschel, S., additional

Published
2018
Full Text
View/download PDF

15. CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa

Author

Schwarz, C., Schulte-Hubbert, B., Bend, J., Abele-Horn, M., Baumann, I., Bremer, W., Brunsmann, F., Dieninghoff, D., Eickmeier, O., Ellemunter, H., Fischer, R., Grosse-Onnebrink, J., Hammermann, J., Hebestreit, H., Hogardt, M., Huegel, C., Hug, M., Illing, S., Jung, A., Kahl, B., Koitschev, A., Mahlberg, R., Mainz, J. G., Mattner, F., Mehl, A., Moeller, A., Muche-Borowski, C., Nuesslein, T., Puderbach, M., Renner, S., Rietschel, E., Ringshausen, F. C., Schmidt, S., Sedlacek, L., Sitter, H., Smaczny, C., Tuemmler, B., Vonberg, R., Wielpuetz, M. O., Wilkens, H., Wollschlaeger, B., Zerlik, J., Dueesberg, U., van Koningsbruggen-Rietschel, S., Schwarz, C., Schulte-Hubbert, B., Bend, J., Abele-Horn, M., Baumann, I., Bremer, W., Brunsmann, F., Dieninghoff, D., Eickmeier, O., Ellemunter, H., Fischer, R., Grosse-Onnebrink, J., Hammermann, J., Hebestreit, H., Hogardt, M., Huegel, C., Hug, M., Illing, S., Jung, A., Kahl, B., Koitschev, A., Mahlberg, R., Mainz, J. G., Mattner, F., Mehl, A., Moeller, A., Muche-Borowski, C., Nuesslein, T., Puderbach, M., Renner, S., Rietschel, E., Ringshausen, F. C., Schmidt, S., Sedlacek, L., Sitter, H., Smaczny, C., Tuemmler, B., Vonberg, R., Wielpuetz, M. O., Wilkens, H., Wollschlaeger, B., Zerlik, J., Dueesberg, U., and van Koningsbruggen-Rietschel, S.

Abstract

Cystic Fibrosis (CF) is the most common autosomal-recessive genetic disease affecting approximately 8000 people in Germany. The disease is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene leading to dysfunction of CFTR, a transmembrane chloride channel. This defect causes insufficient hydration of the epithelial lining fluid which leads to chronic inflammation of the airways. Recurrent infections of the airways as well as pulmonary exacerbations aggravate chronic inflammation, lead to pulmonary fibrosis and tissue destruction up to global respiratory insufficiency, which is responsible for the mortality in over 90% of patients. The main aim of pulmonary treatment in CF is to reduce pulmonary inflammation and chronic infection. Pseudomonas aeruginosa ( Pa ) is the most relevant pathogen in the course of CF lung disease. Colonization and chronic infection are leading to additional loss of pulmonary function. There are many possibilities to treat Pa -infection. This is a S3-clinical guideline which implements a definition for chronic Pa -infection and demonstrates evidence-based diagnostic methods and medical treatment for Pa -infection in order to give guidance for individual treatment options.

Published
2018

16. Poster

Author

Fiebig, H., Weber, B., Cromwell, O., Jutel, M., Fiedler, G., Hanschmann, H., Hansen, I., Stuck, B. A., Hörmann, K., Klimek, L., Jappe, U., Hoffmann, M., Burow, G., Mühlmeier, G., Maier, H., Mušič, E., Košnik, M., Piller, M., Drachenberg, K. J., Urban, E., Schenn, A., Ruëff, F., Weimer, G., Przybilla, B., Sieber, W., Schoppelrey, V., Pfeifer, M., Steiß, J. O., Lindemann, H., Wolf, H., Schnitker, J., Petermann, F., Bergmann, K. C., Zwacka, G., Steinert, B., Markert, U. R., Bijlsma, P. B., Backhaus, B., Weidenhiller, M., Donhauser, N., Hahn, E. G., Raithel, M., Erkelens, W., Hommes, D., Bruno, M., Akkerdaas, J., van Ree, R., Groot, J. A., Taminiau, J. A. J. M., Meinardi, M. M. H. M., Borowski, C., Schäfer, T., Eberhardt, F., Lepp, U., Becker, W.-M., Zabel, P., Hipler, U.-C., Spoo, J., Bauer, A., Elsner, P., Kuefner, M. A., Schwelberger, H. G., Lange, L., Rietschel, E., Riffelmann, F., Lauter, H., Müller, K.-M., Tränkner, A., Mach, K., Reulbach, U., Geyer, D., Leis, B., Ziegert, M., Ahlert, I., Deichmann, K. A., Heinzmann, A., Allmers, H., Beezhold, D., Hamilton, R. G., Sutherland, E. R., Schwanitz, H. J., Scherer, K., Bircher, A. J., Dymek, S., Lex, C., Balzer, S., Schuster, A., Hülsmeier, L., Barker, M., Müller-Lux, A., Göen, T., Koll, W., Koschel, D., Müller-Wening, D., Kütting, B., Janicke, N., Schippke, D., Langer, C., Schulz, T. G., Turowski, S., Drexler, H., Hallier, E., Bickeböller, H., Heutelbeck, A. R. R., Lässig, W., Nordwig, A., Dellweg, D., Schwarz, H., Goldmann, R., Lorenz, C., Achtzehn, U., Stehle, R., Keiper, B., Jilge, B., Beier, L., Schmidt, E. W., van Kampen, V., Haamann, F., Merget, R., Sander, I., Raulf-Heimsoth, M., Rabstein, S., Brüning, T., Ahrens, T., Muesken, H., Bergmann, K.-Ch., Vetter, M., Heitmann, M., Hunzelmann, N., Schuster, J., Kadar, J., Kespohl, S., Petersen, A., Meyer, H. E., Sickmann, A., Kleber, N., Hinrichs, J., Schocker, F., Becker, W. M., Rozynek, P., Dresselhaus, T., Reuter, B., Henzgen, M., Fahlbusch, B., Rudeschko, O., Schlenvoigt, G., Kroegel, C., Rihs, H.-P., Gaspar, Â., Pires, G., Hohenstein, E., Fiedler, E.-M., v. Pelchrzim, R., Focke, M., Zuberbier, T., Worm, M., Janowska, E., Grycmacher-Łapko, V., Kurek, M., Lippert, U., Niedenführ, S., Fuchs, T., Ludwig, A., Koch, A., Balda, B.-R., Oestmann, E., Philipp, S., Spornraft-Ragaller, P., Hammermann, J., Meurer, M., Ott, H., Wurpts, G., Krieg, R., Al Masaoudi, T., Joussen, S., Kiehl, K., Neis, M., Merk, H. F., Baron, J. M., Schmengler, J., John, S. M., Blaschke, V., Bonnekoh, B., Holzamer, N., Schmidt, U., Ambach, A., Oppermann, H., Thriene, B., Gollnick, H., Kraus, T., Häberle, M., Hoopmann, M., Hehl, O., Werfel, T., Heidrich, S., Kelber, J., Hünecke, P., Kasche, A., Klaus, S., Thiel, M., Buters, J., Weichenmeier, I., Ring, J., Traidl-Hoffmann, C., Behrendt, H., Krämer, U., Lau, S., Kim, S., Mahling, H., Schulz, G., Keil, T., Wahn, U., Mock, B., Kugler, J., Cremer, R., Sandner, B., Kaiser, F., Herbst, R. A., Wahl, R., Suck, R., Kügler, K., Frosch, P. J., Nabe, A., Konturek, P., Simon, K., Kressel, J., Nägel, A., Wilken, V., Strehfeld, T., Neubert, K., Pieper, B., Kuhn, M., Winterkamp, S., Pacurar, A., Senger, D., Beskitas, E., Dorrmann, H., Mueller, M. W., Harwanegg, C., Hiller, R., Kinne, R. W., Schröder, C. M., Mahler, V., Schröder, A., Erdmann, S., Schultis, H. W., Buchwald, F., Hampel, W., Maiss, J., Naegel, A., Zahradnik, E., Doekes, G., Runge, D. M., Schwertner, H., Grize, L., Schindler, C., Surber, Ch., Böckelmann, R., Horn, T., Breithaupt, S., Thiele, J. J., Gutermuth, J., Jakob, T., Heinzelmann, J., Varosi, F., Debevc, F., Pöhlmann, T. G., Seyfarth, L., Kindt, F., Löser, C., Niemeier, V., Gieler, U., Kummer, W., Haberberger, R. V., Klockenbring, T., Stöcker, M., Huhn, M., Bauer, R., Goerlich, R., Fischer, R., Barth, S., Suchodolska, A., Soost, S., Bayerl, C., Ludwig, B., Gancs, P., Häusermann, P., Harr, T., Müller, M., Sachs, B., Riegel, S., Schichler, D., Schrooten, J., Heussen, N., Hilgers, R.-D., Seo, J. W., Franke, I., and Strauss, R.

Subjects
SIT und Insektengiftallergie, Immunology and Allergy
Published
2004
Full Text
View/download PDF

17. Factors associated with worse lung function in cystic fibrosis patients with persistent staphylococcus aureus

Author

Junge, S. (Sibylle), Görlich, D. (Dennis), Reijer, M.D. (Martijn Den), Wiedemann, B. (Baerbel), Tümmler, B. (Burkhard), Ellemunter, H., Dübbers, A. (Angelika), Küster, P. (Peter), Ballmann, M., Koerner-Rettberg, C. (Cordula), Große-Onnebrink, J. (Jörg), Heuer, E. (Eberhardt), Sextro, W. (Wolfgang), Mainz, J.G. (Jochen G.), Hammermann, J. (Jutta), Riethmüller, J. (Joachim), Graepler-Mainka, U.M. (Ute M.), Staab, D. (Doris), Wollschläger, B. (Bettina), Szczepanski, R. (Rüdiger), Schuster, A. (Antje), Tegtmeyer, F.-K. (Friedrich-Karl), Sutharsan, S. (Sivagurunathan), Wald, A. (Alexandra), Nofer, J.-R. (Jerzy-Roch), Wamel, W.J.B. (Willem) van, Becker, K. (Karsten), Peters, G. (Georg), Kahl, B.C. (Barbara C.), Junge, S. (Sibylle), Görlich, D. (Dennis), Reijer, M.D. (Martijn Den), Wiedemann, B. (Baerbel), Tümmler, B. (Burkhard), Ellemunter, H., Dübbers, A. (Angelika), Küster, P. (Peter), Ballmann, M., Koerner-Rettberg, C. (Cordula), Große-Onnebrink, J. (Jörg), Heuer, E. (Eberhardt), Sextro, W. (Wolfgang), Mainz, J.G. (Jochen G.), Hammermann, J. (Jutta), Riethmüller, J. (Joachim), Graepler-Mainka, U.M. (Ute M.), Staab, D. (Doris), Wollschläger, B. (Bettina), Szczepanski, R. (Rüdiger), Schuster, A. (Antje), Tegtmeyer, F.-K. (Friedrich-Karl), Sutharsan, S. (Sivagurunathan), Wald, A. (Alexandra), Nofer, J.-R. (Jerzy-Roch), Wamel, W.J.B. (Willem) van, Becker, K. (Karsten), Peters, G. (Georg), and Kahl, B.C. (Barbara C.)

Abstract

Background Staphylococcus aureus is an important pathogen in cystic fibrosis (CF). However, it is not clear which factors are associated with worse lung function in patients with persistent S. aureus airway cultures. Our main hypothesis was that patients with high S. aureus density in their respiratory specimens would more likely experience worsening of their lung disease than patients with low bacterial loads. Methods Therefore, we conducted an observational prospective longitudinal multi-center study and assessed the association between lung function and S. aureus bacterial density in respiratory samples, co-infection with other CF-pathogens, nasal S. aureus carriage, clinical status, antibiotic therapy, IL-6- and IgG-levels against S. aureus virulence factors. Results 195 patients from 17 centers were followed; each patient had an average of 7 visits. Data were analyzed using descriptive statistics and generalized linear mixed models. Our main hypothesis was only supported for patients providing throat specimens indicating that patients with higher density experienced a steeper lung function decline (p<0.001). Patients with exacerbations (n = 60), S. aureus small-colony variants (SCVs, n = 84) and co-infection with Stenotrophomonas maltophilia (n = 44) had worse lung function (p = 0.0068; p = 0.0011; p = 0.0103). Patients with SCVs were older (p = 0.0066) and more often treated with trimethoprim/sulfamethoxazole (p = 0.0078). IL-6 levels positively correlated with decreased lung function (p<0.001), S. aureus density in sputa (p = 0.0016), SCVs (p = 0.0209), exacerbations (p = 0.0041) and co-infections with S. maltophilia (p = 0.0195) or A. fumigatus (p = 0.0496). Conclusions In CF-patients with chronic S. aureus cultures, independent risk factors for worse lung function are high bacterial density in throat cultures, exacerbations, elevated IL-6 levels, presence of S. aureus SCVs and co-infection with S. maltophilia.

Published
2016
Full Text
View/download PDF

18. Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus

Author

Junge, S, Gorlich, D, Reijer, Martijn, Wiedemann, B, Tummler, B, Ellemunter, H, Dubbers, A, Kuster, P, Ballmann, M, Koerner-Rettberg, C, Grosse-Onnebrink, J, Heuer, E, Sextro, W, Mainz, J G, Hammermann, J, Riethmuller, J, Graepler-Mainka, U, Staab, D, Wollschlager, B, Szczepanski, R, Schuster, A, Tegtmeyer, F K, Sutharsan, S, Wald, A, Nofer, J R, van Wamel, Willem, Becker, K, Peters, G, Kahl, B C, Junge, S, Gorlich, D, Reijer, Martijn, Wiedemann, B, Tummler, B, Ellemunter, H, Dubbers, A, Kuster, P, Ballmann, M, Koerner-Rettberg, C, Grosse-Onnebrink, J, Heuer, E, Sextro, W, Mainz, J G, Hammermann, J, Riethmuller, J, Graepler-Mainka, U, Staab, D, Wollschlager, B, Szczepanski, R, Schuster, A, Tegtmeyer, F K, Sutharsan, S, Wald, A, Nofer, J R, van Wamel, Willem, Becker, K, Peters, G, and Kahl, B C

Published
2016

21. S2-Konsensus-Leitlinie 'Diagnose der Mukoviszidose'

Author

Naehrlich, L, Stuhrmann-Spangenberg, M, Barben, J, Bargoni, J, Blankenstein, O, Bremern, W, Brunsmann, F, Ellemunter, H, Fusch, C, Gembruch, U, Hammermann, J, Jacobeit, J, Jung, A, and University of Zurich

Subjects
10036 Medical Clinic, 610 Medicine & health
Published
2013

22. Inhalation treatment with glutathione in patients with cystic fibrosis: A randomized clinical trial

Author

Griese, M., Kappler, M., Eismann, C., Ballmann, M., Junge, S., Rietschel, E., van Koningsbruggen-Rietschel, S., Staab, D., Rolinck-Werninghaus, C., Mellies, U., Köhnlein, T., Wagner, T., König, S., Teschler, H., Heuer, H.E., Kopp, M., Heyder, S., Hammermann, J., Küster, P., Honer, M., Mansmann, U., Beck-Speier, I., Hartl, D., Fuchs, C., Glutathione Study Group (), and Hector, A.

Subjects
Adult, Male, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Antioxidant, Cystic Fibrosis, medicine.medical_treatment, Medizin, Critical Care and Intensive Care Medicine, Placebo, Cystic fibrosis, Gastroenterology, Antioxidants, law.invention, Young Adult, chemistry.chemical_compound, Double-Blind Method, Randomized controlled trial, Inhaled Therapy, Glutathione, Clinical Trial, law, Forced Expiratory Volume, Internal medicine, Administration, Inhalation, medicine, Humans, Lung, Inhalation, business.industry, medicine.disease, Respiratory Function Tests, Surgery, Clinical trial, Treatment Outcome, medicine.anatomical_structure, chemistry, Female, business
Abstract

Rationale: Glutathione is the major antioxidant in the extracellular lining fluid of the lungs and depleted in patients with cystic fibrosis (CF). Objectives: We aimed to assess glutathione delivered by inhalation as a potential treatment for CF lung disease. Methods: This randomized, double-blind, placebo-controlled trial evaluated inhaled glutathione in subjects with CF 8 years of age and older and FEV1 of 40-90% of predicted. Subjects were randomized to receive 646 mg glutathione in 4 ml (n = 73) or placebo (n = 80) via an investigational eFlow nebulizer every 12 hours for 6 months. Measurements and Main Results: FEV1 (absolute values), both as pre-post differences (P = 0.180) and as area under the curves (P = 0.205), were the primary efficacy endpoints, and were not different between the glutathione group and the placebo group over the 6-month treatment period. Exploratory analysis showed an increase of FEV1 from baseline over placebo of 100 ml or 2.2% predicted; this was significant at 3 months, but not later. Subjects receiving glutathione had neither fewer pulmonary exacerbations, nor better scores for quality of life. Whereas increased glutathione and metabolites in sputum demonstrated significant delivery to the lungs, there was no indication of diminished oxidative stress to proteins or lipids, and no evidence for anti-inflammatory or antiproteolytic actions of glutathione supplemented to the airways. The adverse event incidence was similar between glutathione and placebo. Conclusions: Inhaled glutathione in the dose administered did not demonstrate clinically relevant improvements in lung function, pulmonary exacerbation frequency, or patient-reported outcomes. Glutathione delivery to the airways was not associated with changes in markers of oxidation, proteolysis, or inflammation. Clinical trial registered with www.clinicaltrials.gov (NCT00506688) and https://eudract.ema.europa.eu/index.html (EudraCT 2005-003870-88).

Published
2013

27. 164 Neutrophil elastase-mediated increase in airway temperature during inflammation

Author

Döring, G., primary, Schmidt, A., additional, Bissinger, R., additional, Koller, G., additional, Malleret, L., additional, D'Orazio, C., additional, Assael, B.M., additional, Facchinelli, M., additional, Piacentini, G., additional, Schulte-Hubbert, B., additional, Hammermann, J., additional, Schniedejans, M., additional, Häußler, S., additional, Meyer, K.C., additional, Worlitzsch, D., additional, Damkir, S., additional, Bruce, K.D., additional, Belaaouaj, A., additional, Lipuma, J.J., additional, and Seelig, J., additional

Published
2013
Full Text
View/download PDF

28. WS19.9 A prospective multicenter study to dissect Staphylococcus aureus-colonization from infection in cystic fibrosis patients

Author

Junge, S., primary, Wiedemann, B., additional, Tümmler, B., additional, Dübbers, A., additional, Küster, P., additional, Nofer, J., additional, Ellemunter, H., additional, Mainz, J.G., additional, Heuer, E., additional, Sextro, W., additional, Körner-Rettberg, C., additional, Ballmann, M., additional, Mellies, U., additional, Hammermann, J., additional, Teschler, H., additional, Szczepanski, R., additional, Tegtmeyer, F.K., additional, Graepler-Mainka, U., additional, Riethmueller, J., additional, Wald, A., additional, Wollschläger, B., additional, Staab, D., additional, Schuster, A., additional, Becker, K., additional, Peters, G., additional, and Kahl, B.C., additional

Published
2013
Full Text
View/download PDF

30. WS5.1 Inhaled glutathione in cystic fibrosis

Author

Griese, M., primary, Hector, A., additional, Kappler, M., additional, Ballmann, M., additional, Junge, S., additional, Rietschel, E., additional, Staab, D., additional, van Koningsbruggen, S., additional, Rolinck-Werninghaus, C., additional, Mellis, U., additional, Köhnlein, T., additional, Wagner, T., additional, Cörner-Rettberg, C., additional, Teschler, H., additional, Heuer, E., additional, Kopp, M., additional, Heyder, S., additional, Hammermann, J., additional, Küster, P., additional, Reimann, A., additional, Honer, M., additional, Mansmann, U., additional, and Eismann, C., additional

Published
2012
Full Text
View/download PDF

44. MEASUREMENT OF PANCREATITIS-ASSOCIATED PROTEIN IN COMBINATION TO IMMUNOREACTIVE TRYPSINOGEN FOR NEONATAL SCREENING STRATEGY OF CF: A MULTICENTER FEASIBILITY STUDY

Author

Vigano, P., primary, Corbetta, C., additional, Mariani, T., additional, Cattaneo, C., additional, Bj¨orklund, C., additional, Kasel, M., additional, Karvonen, H., additional, Hoffman, G.H., additional, Laessig, R.H., additional, Kopish, G.J., additional, Eaton, R., additional, Comeau, A., additional, Stopsack, M., additional, Hammermann, J., additional, Nilson, N., additional, Heine, C., additional, Fenner, J., additional, and Dagorn, J.C., additional

Published
2008
Full Text
View/download PDF

46. N17 - Diagnose der Mukoviszidose (S2)

Author

NÄHRLICH, L., STUHRMANN-SPANGENBERG, M., BARBEN, J., BARGON, J., BLANKENSTEIN, O., BREMER, W., BRUNSMANN, F., BUCHHOLZ, T., ELLEMUNTER, H., FUSCH, C., GEMBRUCH, U., HAMMERMANN, J., JACOBEIT, J., JUNG, A., KEIM, V., KOPP, I., LOFF, S., MAYR, S., PFEIFFER-AULER, S., ROSSI, R., SITTER, H., STERN, M., STRASSBURG, C., and DERICHS, N.

Published
2015
Full Text
View/download PDF

47. Insektengiftallergie — Anti-IgE-Therapie

Author

Sieber, W., primary, Pfützner, W., additional, Löffler, H., additional, Hertl, M., additional, Moeser, A., additional, Henzgen, M., additional, Kroegel, C., additional, Weiß, A., additional, Lützkendorf, L., additional, Höffken, G., additional, Koschel, D., additional, Wieczorek, D., additional, Kapp, A., additional, Wedi, B., additional, Bethge, C., additional, Hauswald, B., additional, Uecker, F., additional, Zahnert, T., additional, Rerinck, H. C., additional, Przybilla, B., additional, Ruëff, F., additional, Nemat, K., additional, Gurth, H., additional, Hammermann, J., additional, Vogelberg, C., additional, Eberle, P., additional, Hamelmann, E., additional, Kopp, M., additional, Schulze, J., additional, Steiß, J., additional, Steiß, J. O., additional, Schüler, D., additional, Simon, M., additional, Strohner, P., additional, Lindemann, H., additional, Zimmer, K., additional, Holz, M., additional, Klimek, L., additional, Pfaar, O., additional, Fuchs, T., additional, and Mössner, R., additional

Published
2007
Full Text
View/download PDF

48. 26. ÄDA-Kongress

Author

Sennekamp, J., primary, Wendl, M., additional, aufm Kampe, Adelheid, additional, Lattermann, V., additional, Lohmann, D., additional, Kaldewey, M., additional, Wahl, R., additional, Hipler, U.-C., additional, Bauer, A., additional, Elsner, P., additional, Gäullein, Jürgen, additional, Voigts, Jochen, additional, Zwacka, Gerhard, additional, Markert, Udo R., additional, Schreiber, J., additional, Göring, H.-D., additional, Strüben, C., additional, Rosahl, W., additional, Amthor, M., additional, Schneider, M., additional, Hilgers, R. D., additional, Vogelberg, Christian, additional, Hirsch, Thomas, additional, Leupold, Wolfgang, additional, Eisner, P., additional, Berghem, Stefan, additional, and Hammermann, J., additional

Published
2000
Full Text
View/download PDF

49. MOLECULAR ANALYSIS OF STAPHYLOCOCCUS AUREUS ISOLATES FROM AN ONGOING PROSPECTIVE OBSERVATIONAL LONGITUDINAL MULTICENTER STUDY DETERMINING STAPHYLOCOCCUS AUREUS AIRWAY COLONIZATION OR INFECTION IN CYSTIC FIBROSIS PATIENTS

Author

Braun, N., Duebbers, A., Kuester, P., Ellemunter, H., Heuer, E., Sextro, W., Junge, S., Tuemmler, B., Mellies, U., Teschler, H., Mainz, J. G., Riethmueller, J., Graepler-Mainka, U., Cordula Koerner-Rettberg, Ballmann, M., Szczepanski, R., Wald, A., Wisbauer, M., Adelsberger, D., Staab, D., Wollschlager, B., Hammermann, J., Peters, G., Becker, K., and Kahl, B. C.

Subjects
Medizin

50. [CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa].

Author

Schwarz C, Bend J, Hebestreit H, Hogardt M, Hügel C, Illing S, Mainz JG, Rietschel E, Schmidt S, Schulte-Hubbert B, Sitter H, Wielpütz MO, Hammermann J, Baumann I, Brunsmann F, Dieninghoff D, Eber E, Ellemunter H, Eschenhagen P, Evers C, Gruber S, Koitschev A, Ley-Zaporozhan J, Düesberg U, Mentzel HJ, Nüßlein T, Ringshausen FC, Sedlacek L, Smaczny C, Sommerburg O, Sutharsan S, Vonberg RP, Weber AK, and Zerlik J

Abstract

Competing Interests: Disclosure The authors report no conflicts of interest in this work.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results